CytoSorbents Corp (NASDAQ:CTSO) is set to release its Q4 2024 earnings on Mar 6, 2025. The consensus estimate for Q4 2024 revenue is $10.10 million, and the earnings are expected to come in at -$0 ...

C ytosorbents Corporation (NASDAQ:CTSO) stock has reached a notable milestone, hitting a 52-week high of $1.6, signaling a period of strong performance for the medical device company. According to ...